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Fine-mapping host genetic variation
underlying outcomes to Mycobacterium
bovis infection in dairy cows
S. Wilkinson1*, S.C. Bishop1ˆ, A.R. Allen2, S.H. McBride2, R.A. Skuce2,3, M. Bermingham1,4, J.A. Woolliams1
and E.J. Glass1
Abstract
Background: Susceptibility to Mycobacterium bovis infection in cattle is governed in part by host genetics.
However, cattle diagnosed as infected with M. bovis display varying signs of pathology. The variation in host
response to infection could represent a continuum since time of exposure or distinct outcomes due to differing
pathogen handling. The relationships between host genetics and variation in host response and pathological
sequelae following M. bovis infection were explored by genotyping 1966 Holstein-Friesian dairy cows at 538,231
SNPs with three distinct phenotypes. These were: single intradermal cervical comparative tuberculin (SICCT) test
positives with visible lesions (VLs), SICCT-positives with undetected visible lesions (NVLs) and matched controls
SICCT-negative on multiple occasions.
Results: Regional heritability mapping identified three loci associated with the NVL phenotype on chromosomes
17, 22 and 23, distinct to the region on chromosome 13 associated with the VL phenotype. The region on
chromosome 23 was at genome-wide significance and candidate genes overlapping the mapped window included
members of the bovine leukocyte antigen class IIb region, a complex known for its role in immunity and disease
resistance. Chromosome heritability analysis attributed variance to six and thirteen chromosomes for the VL and
NVL phenotypes, respectively, and four of these chromosomes were found to explain a proportion of the
phenotypic variation for both the VL and NVL phenotype. By grouping the M. bovis outcomes (VLs and NVLs)
variance was attributed to nine chromosomes. When contrasting the two M. bovis infection outcomes (VLs vs NVLs)
nine chromosomes were found to harbour heritable variation. Regardless of the case phenotype under
investigation, chromosome heritability did not exceed 8% indicating that the genetic control of bTB resistance
consists of variants of small to moderate effect situated across many chromosomes of the bovine genome.
Conclusions: These findings suggest the host genetics of M. bovis infection outcomes is governed by distinct and
overlapping genetic variants. Thus, variation in the pathology of M. bovis infected cattle may be partly genetically
determined and indicative of different host responses or pathogen handling. There may be at least three distinct
outcomes following M. bovis exposure in dairy cattle: resistance to infection, infection resulting in pathology or no
detectable pathology.
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Background
Bovine tuberculosis (bTB), caused by Mycobacterium
bovis, a member of the Mycobacterium tuberculosis com-
plex, is a disease that adversely affects cattle in many
parts of the world. The zoonotic pathogen impacts the
health and welfare of cattle and there is the additional
risk of spread of infection to other mammalian species.
Prevalence of bTB has increased in the United Kingdom
since the mid-1980s, particularly in the higher risk areas
of Wales and South-West of England [1]. To tackle bTB
the government currently implements active surveillance
and bTB eradication measures including routine diag-
nostic testing of herds using the tuberculin skin test, cul-
ling of test reactor animals, movement restrictions on
infected herds and abattoir surveillance. However, des-
pite the eradication programme recent trends indicate
that bTB continues to persist in the UK [1].
Resistance to M. bovis infection in cattle is complex,
with quantitative genetic studies showing that the trait is
influenced, in part, by host genetic variation. Moderate
heritable variation for bTB resistance has been found for
both dairy [2, 3] and beef populations [4], indicating that
breeding for increased bTB resistance in cattle is a viable
strategy to reduce the prevalence and spread of the
disease in the national herds. A recent study on the
prediction of disease susceptibility in dairy cows using
genetic markers demonstrated that genomic selection for
bTB resistance is feasible and could therefore be comple-
mentary to current control measures [5]. In addition, dis-
section of the genomic architecture of the trait has
revealed many bTB resistance loci mapped to several
chromosomes for different cattle populations [6–9].
After establishment of infection a range of outcomes
can manifest in the host. It is recognised that human tu-
berculosis (TB) infection, caused by the highly-related
mycobacterium, M. tuberculosis, is manifest in at least
two clinical phenotypes, latent and active TB [10] with
most infected humans classified as latent with no clinical
symptoms, and around 10% developing symptoms, most
commonly as a pulmonary disease. Furthermore, Young
et al. [11] proposed that the host TB spectrum could be
extended to include an asymptomatic subclinical state
and a wider range of host responses including clearance
of infection through innate or acquired immune mecha-
nisms [11]. Many factors play a role in determining how
exposed individuals respond to infection and whether
they ultimately succumb to clinical disease. Given the
complexity of the host-pathogen interactions that occur
during infection with M. tuberculosis, it is not surprising
that host genetics also plays a role in influencing the
outcome of infection [12]. However, reflecting the diffi-
culties in testing directly for infection with or exposure
to M. tuberculosis, the majority of human genetic studies
have focused on susceptibility to pulmonary disease as
this phenotype is easier to diagnose [12]. Nonetheless,
attention is now turning to the suggestion that poten-
tially distinct genetics may also control other measure-
able phenotypes within the host TB spectrum including
skin test reactivity in humans [12–15].
A spectrum of host phenotype responses could also be
considered for bTB [16]. Similar to human TB, there is ob-
served variation in pathology amongst cattle infected with
M. bovis [17]. In addition, as in humans, the bTB diagnos-
tic tests are limited and show variation in specificity and
sensitivity and a lack of correlation between tests
(reviewed by Strain et al., [18]). For instance, all animals
diagnosed as infected using the single intradermal com-
parative cervical tuberculin (SICCT) test undergo carcase
abattoir examination for signs of disease pathology and
typically around 30 to 40% of these are confirmed for M.
bovis infection in the form of tubercle lesions (VL) [19].
The remaining 60–70% of animals that are skin-test posi-
tive but not displaying detectable signs of pathology at
carcase abattoir examination (NVL) could be expressing a
phenotype that is indicative of a time lag due to early stage
infection, a state of latency or other environmental factors
such as low dose of pathogen challenge [17]. Additionally,
the NVL diagnosis may also represent a divergent host re-
sponse phenotype under distinct host genetics.
This paper explores these hypotheses by extending an
earlier VL case–control genome-wide association study
(GWAS) on bTB resistance [6] to quantify genetic vari-
ation associated with the NVL phenotype and compare
with data on the VL phenotype. The aim of the study is
to dissect the genetic architecture of the outcomes of M.
bovis infection in dairy cattle.
Results
Regional heritability (RH) mapping
RH mapping was conducted [20] to identify regions of
genetic variance associated with M. bovis infection out-
comes. A previous bTB case–control study, reported a
quantitative trait locus (QTL) on BTA13 associated with
the VL phenotype (controls vs VLs) detected by RH
mapping [6]. The extra 19 re-genotyped VLs in the
current study produced concordant results and therefore
these results are not reported further.
Regions of genetic variance associated with NVL pheno-
type (controls vs NVLs), cases (controls vs VLs and NVLs)
and NVLs vs VLs detected by RH mapping using 100-
SNP windows are presented in Fig. 1 and Table 1. The re-
gion on BTA13 previously identified for the VL phenotype
by Bermingham et al., [6] was not detected for the NVL
phenotype using RH mapping. Single SNP-based GWAS
identified two SNPs at suggestive significance on BTA13
associated with the NVL phenotype, but they were
approximately 7 Mb and 13 Mb distant from the QTL re-
ported by Bermingham et al., [6] (Additional files 1 and 2).
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Fig. 1 Regional heritability for bTB resistance. Shown is the likelihood ratio test (LRT) across the genome using 100-SNP windows for a controls vs
NVLs, b control vs cases and c NVLs vs VLs. Genome-wide (P < 0.05) and suggestive significance (one false positive per genome scan) LRT thresh-
olds are shown as a dashed and dotted line, respectively
Table 1 Genomic regions associated with bTB resistance
chr Position (bp) LRT h2r Candidate Genes
NVLs 100-SNP windows
17 19,342,437–19,650,334 15.10 0.053 LOC783390 matrin 3 pseudogene
22 57,159,725–57,547,638 17.42 0.039 RAF1, MKRN2, MKRN2OS, TSEN2, PPARG, MIR2373
23 6,603,103–7,066,824 20.05 0.035 LRRC1, LOC104975626, KLHL31, GCLC, DSB, BOLA-DYA,
BOLA-DYB, BOLA-DOB, LOC100140517
30-SNP windows
22 57,311,814–57,451,910 16.87 0.026 TSEN2, PPARG
22 57,396,014–57,510,400 17.61 0.025 PPARG, MIR2373
23 6,669,083–6,873,884 20.00 0.041 LOC104975626, KLHL31
23 6,774,875–6,975,825 16.64 0.046 KLHL31, GCLC, DSB
Cases 100-SNP windows
23 6,411,854–6,774,223 15.12 0.033 MLIP, LRRC1, LOC104975626, KLHL31
For the associated trait, the table shows chromosome, start and end position of genomic window in base pairs, LRT, heritability of the region and candidate genes
residing within the window of significance. Genomic regions at both the genome-wide and suggestive level identified by regional heritability mapping using 100-
and 30-SNP window size are presented
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Instead, RH mapping identified three QTLs distinct to
NVLs, two regions at suggestive significance and one re-
gion at genome-wide significance (Fig. 1a). The first region
at suggestive significance was on BTA17 spanning 19.34–
19.65 Mb. Within this region was one uncharacterised
gene, a pseudogene, and nearby was the solute carrier
SLC7A11, which fell within an adjacent overlapping
window that was just below suggestive significance
(19.51–19.83 Mb, LRT = 13.86, h2r = 0.044). Fine RH
mapping of the associated region on BTA17 failed to
resolve this QTL as no regions were detected at
genome-wide or suggestive significance. The second
region at suggestive significance was located at 57.16–
57.54 Mb on BTA22 comprising a moderately gene-
rich region with six genes found. Fine RH mapping of
the associated region improved the resolution of the
QTL, revealing two overlapping 30-SNP windows at
suggestive significance located at 57.31–57.51 Mb
(Fig. 2). Within the two 30-SNP windows were the
genes TSEN2 (57.27–57.32 Mb), PPARG (57.36–
57.43 Mb) and MIR2373 (57.48–57.49 Mb) and SNPs
were found to be just below the suggestive signifi-
cance level for the single SNP-based GWAS (Fig. 2).
The third region, which reached genome-wide signifi-
cance level, was on BTA23 extending from 6.60–
7.06 Mb. This region was relatively gene rich and in-
cluded members of the bovine leukocyte antigen
(BoLA) class IIb (6.97–7.53 Mb) also falling under the
significant window. Fine RH mapping of the associ-
ated region revealed two overlapping 30-SNP windows
at suggestive significance (Fig. 3). Within these win-
dows there were also two SNPs at suggestive signifi-
cance at 6.774 Mb and 6.777 Mb detected by the
single SNP-based GWAS (Fig. 3; Additional files 1
and 2). Within the region were the genes KLHL31
(6.77–6.78 Mb), GCLC (6.92–6.96 Mb) and DSB
(6.97–6.99 Mb).
RH mapping of all cases (VLs and NVLs) revealed
one window at suggestive significance, located on
BTA23 at 6.41–6.77 Mb (Fig. 1b). This window over-
lapped those detected on BTA23 for the NVL
phenotype and downstream from this window is the
BoLA class IIb region. Fine RH mapping of the
whole genome using 50- and 30-SNP windows re-
sulted in no windows at suggestive or genome-wide
significance.
Considering the comparison between the NVL and VL
phenotypes (NVLs vs VLs), RH mapping using a 100-SNP
window failed to detect regions at the genome-wide or
suggestive significance levels (Fig. 1c). Regions just
below the suggestive significance level were located on
BTA7 (111.52–111.78 Mb, LRT = 9.57), BTA9 (98.14–
98.53 Mb, LRT = 11.88) and BTA18 (49.40–49.83 Mb,
LRT = 10.21). Fine mapping of these chromosomes
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Fig. 2 Associations at the region on BTA22 detected in the NVL phenotype (controls vs NVLs). The top panel shows RH mapping results using
30-SNP windows with the LRT plotted with respect to genomic position on BTA22. A grey rectangle highlighting 30-SNP windows significant at
the suggestive level. The middle panel shows the associations (−log10(P-value)) from the GWAS for SNPs located within and flanking the RH
mapped region of significance. The shaded colour boxes in this panel indicate the genomic position of the RH mapped region of significance with
corresponding LRT values displayed in the legend box to the right. The bottom panel shows the protein coding regions within and flanking the
RH mapped region of significance. These were obtained using the bioconductor annotation R package [53] with the full genome sequence for
Bos taurus provided by UCSC [54]
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detected a 30-SNP window at suggestive significance on
BTA9 (98.34–98.49 Mb, LRT = 18.02, h2r = 0.030). There
were three candidate genes located within the 100-SNP
window, MAP3K4 (98.12–98.23 Mb), AGPAT4 (98.23–
98.37 Mb) and PARK2 (98.42–98.45 Mb) with the third
gene residing within the 30-SNP window. No significant
SNPs from the GWAS analysis were found within the top
RH mapped windows (Additional files 1 and 2).
Chromosome heritability
The variance attributable to each chromosome was
estimated using a single chromosome decomposition
that included a genome-wide polygenic effect of the
remaining SNPs (i.e. the model fitted a GRM for the
target chromosome along with a whole-genome GRM
constructed for all other chromosomes excluding the
target chromosome).
For the case phenotype VLs (controls vs VLs), six
chromosomes explained a proportion of phenotypic
variance (Fig. 4a). In contrast, variance was attributed
to thirteen chromosomes for the NVL phenotype (Fig.
4b). Four of these chromosomes, BTA3, BTA7,
BTA14 and BTA22, were also found to explain a
proportion of phenotypic variance for the VLs (con-
trols vs VLs). Confirming RH mapping, the highest
chromosomal heritability estimates for the NVLs were
chromosomes with detected QTLs, i.e. BTA17, BTA22
and BTA23.
When the two M. bovis infection phenotypes were
grouped together (controls vs all cases), variance was
attributed to ten chromosomes (Fig. 4c). Of these
chromosomes, BTA3, BTA7, BTA14 and BTA22 were
found to explain a proportion of phenotypic variance
when the case phenotype was either the VLs or the
NVLs. Of the six other chromosomes, BTA5, BTA13,
BTA17, BTA19 and BTA23 explained a proportion of
phenotypic variance for the NVLs and BTA6 ex-
plained a proportion of phenotypic variance for the
VL phenotype.
Considering NVLs vs VLs, variance was attributed to nine
chromosomes (Fig. 4d). Five of these chromosomes distin-
guished the two case phenotypes, in that they explained a
proportion of phenotypic variance for the NVLs but not for
the VLs (BTA5, BTA13, BTA16, BTA17 and BTA29). Three
additional chromosomes also explained a proportion of the
phenotypic variance for one of the case phenotypes but the
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Fig. 3 Associations at the region on BTA23 detected in the NVL phenotype (controls vs NVLs). The top panel shows RH mapping results using
30-SNP windows with the LRT plotted with respect to genomic position on BTA23. A grey rectangle highlighting 30-SNP windows significant at
the suggestive level. The middle panel shows the associations (−log10(P-value)) from the GWAS for SNPs located within and flanking the RH
mapped region of significance. The shaded colour boxes in this panel indicate the genomic position of the RH mapped region of significance with
corresponding LRT values displayed in the legend box to the right. The bottom panel shows the protein coding regions within and flanking the
RH mapped region of significance. These were obtained using the bioconductor annotation R package [53] with the full genome sequence for
Bos taurus provided by UCSC [54]
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estimates were not significantly different from zero (BTA28
for the VLs and BTA11 and BTA18 for the NVLs). Heritable
variation was found for BTA7 when the phenotype consid-
ered was either VLs, NVLs or all SICCT positive cases.
There was no evidence for a linear relationship between
chromosome length and chromosome heritability (con-
trols vs VLs, P = 0.28 and R2 = 0.007; controls vs NVLs,
P = 0.29 and R2 = 0.005; controls vs cases, P = 0.67 and
R2 = −0.03; NVLs vs VLs, P = 0.89 and R2 = −0.036).
Genome wide association study
Results from the genome-wide association analysis are
reported in the supplementary material (Additional files 1, 2,
3, 4 and 5). Briefly, whilst SNPs were significantly associated
with the NVLs (controls vs NVLs), cases (controls vs cases)
and NVLs vs VLs there were no clear regions of association
detected because significant SNPs were not neighbouring or
in close proximity to one another.
Discussion
Regional heritability (RH) mapping and chromosomal herit-
ability revealed a number of genomic regions and chromo-
somes with heritable variation significantly associated with
the M. bovis infection outcomes defined in this study. The
genetic architecture underlying the two case phenotypes
(VLs and NVLs) appears to be partly distinct, although they
are highly genetically correlated. Our results suggest there
are (at least) two distinct outcomes following M. bovis in-
fection in dairy cattle. In addition, the chromosomal vari-
ance associated with each M. bovis infection outcome and
all cases was not apportioned across the entire bovine gen-
ome and the proportion of variance explained by each
chromosome length was not proportional to its length. This
is consistent with a moderately polygenic model, suggesting
that bTB resistance is under the control of a large number
of regions with variants of small effect size distributed
across certain chromosomes. The controls were animals
a
b
c
d
Fig. 4 Proportion of phenotypic variance explained by each chromosome for bTB resistance. Shown are the chromosome heritability estimates
for a controls vs VLs, b controls vs NVLs, c controls vs cases and d NVLs vs VLs. Dark blue bars represent chromosome heritability estimates
greater than their standard errors and lightly shaded blue bars represent chromosome heritability estimates less than their standard errors
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that were SICCT test negative on multiple occasions fol-
lowing herd breakdown and thus they appear able to resist
or clear M. bovis infection without resorting to a detectable
acquired immune response.
Mapped QTLs associated with bTB resistance
GWAS and RH mapping, respectively, identified a num-
ber of SNPs and regions associated with bTB resistance.
However, strong and informative QTL effects were not
detected by the single SNP-based GWAS as the signifi-
cant SNPs were singletons (prompting the perception
that they may be false positives). RH mapping combines
the effects of neighbouring SNPs into a single estimate
of heritability, thereby increasing the power of detecting
a QTL otherwise tagged by individual SNPs of small
effect [20]. As observed in other studies [21, 22], RH
mapping identified additional loci undetected by single
SNP-based GWAS.
The strongest QTL detected by RH mapping and the
only one at genome-wide level for NVLs (vs controls)
was found on BTA23. In addition, the GWAS revealed
two SNPs at suggestive significance residing within this
region. Genes underlying this QTL included glutamate
cysteine ligase catalytic subunit (GCLC) and members of
the bovine leukocyte antigen (BoLA) class IIb region.
GCLC is a rate-limiting enzyme in the glutathione syn-
thesis pathway and has been found to be differentially
expressed in bovine macrophages in response to patho-
gens, including Salmonella enterica [23] and M. bovis
(unpublished work, pers. comm. K Jensen). The BoLA
class IIb region is part of the BoLA complex, the bovine
equivalent of the Major Histocompatibility Complex
(MHC), which plays a central role in adaptive immunity.
BoLA genes encode cell surface molecules that process
and present pathogen peptide fragments (antigens) to T
cells [24]. The DY genes, which are at the start of the
class IIb region and were found residing in the QTL de-
tected for the NVL phenotype, are unique to ruminants
and may have a specialised role in antigen presentation
to ruminant dendritic cells [25]. The other BoLA classes,
including class IIa, are separated from class IIb by
~17 Mb of sequence on BTA23 due to an historical in-
version event [26]. Although no associations with M.
bovis susceptibility were detected for the other BoLA
classes in the current or other bTB studies, it is clear
that the BoLA class II alleles influence recognition of M.
bovis T cell epitopes [16]. Furthermore, the concentra-
tion of polymorphic immune-related loci on BTA23 may
account for it possessing the highest chromosome herit-
ability for NVLs, explaining 7.7% of the phenotypic vari-
ation of bTB resistance. In addition, the current
bovineHD chip has relatively sparse coverage of SNPs
across the BoLA complex and poor assembly of this gen-
ome region may explain the lack of detectable QTL for
bTB resistance in other regions on BTA23 in this and
previous bTB GWAS studies.
This QTL on BTA23 was also detected for all cases
(controls vs cases), albeit at the suggestive level. It
was not detected in VLs, nor did the chromosome as
a whole explain a proportion of the phenotypic vari-
ation for the VL phenotype suggesting this QTL may
be associated with an M. bovis infection outcome
with no detectable pathology. This region was within
3 Mb of another highly significant bTB resistance
QTL recently reported by Richardson et al., [8], a
study using estimated breeding values (EBVs) for bTB
resistance derived from SICCT data in a cattle popu-
lation distinct from our study. Thus, this region of
the genome could be a prime candidate associated
with bTB resistance in dairy cattle.
A second strong QTL, only detected in NVLs, was on
BTA22, approximately 1 Mb upstream from a QTL re-
portedly associated with bTB resistance EBVs [7]. Fine
mapping of the QTL associated with the NVL pheno-
type resolved a 70 kb block and of the genes in the win-
dow peroxisome proliferator-activated receptor gamma
(PPAR-γ) was identified as a likely candidate gene be-
cause of evidence of a role in immunity. PPAR-γ is a
lipid sensing receptor expressed by macrophages and
dendritic cells [27] and up-regulated in the presence of
M. tuberculosis [28]. It has been shown to detect M.
tuberculosis lipids in infected macrophages leading to in-
hibition of phagolysosome maturation and enhanced
survival of the bacteria [29]. Thus, PPAR-γ associated
variants may play a role in the variation in bTB outcome
following infection in dairy cattle.
Additional putative regions associated with bTB resist-
ance were detected on BTA17 and BTA9, the former as-
sociated with the NVL phenotype and the latter found
to distinguish the two M. bovis infection outcomes
(NVLs vs VLs). Both these QTLs were novel to this
study, but the evidence of association was relatively low,
thus there is the possibility that they were false positives.
In addition, the QTL on BTA17 occurred in a relatively
gene poor region and whilst the QTL on BTA9 con-
tained a few genes there were no obvious candidates
previously associated with disease resistance.
The bTB resistance QTL associated with the VLs (vs
controls) on BTA13 reported by Bermingham et al., [6]
was not detected for the NVLs, all cases or when
contrasting the NVLs with the VLs using the single
SNP-based GWAS and window-based RH mapping.
Similarly, studies where the phenotype was expressed as
bTB resistance EBVs derived from SICCT records
(therefore using both VLs and NVLs to obtain the
phenotype) also did not detect this QTL [7, 8]. The
results suggest that the QTL on BTA13 may only be
associated with detectable bTB pathology in dairy cattle.
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The host genetics of infection outcome with M. bovis
Taking all of the evidence together it would appear that
there are at least three potential outcomes following ex-
posure to M. bovis in dairy cattle. There is a group of
animals that are resistant to infection and may employ
innate immune-related mechanisms to prevent establish-
ment of M. bovis and thus are able to eradicate the
pathogen without invoking the delayed type hypersensi-
tivity response that is measured by the SICCT test or
interferon-γ assay [30]. Similarly, many humans exposed
to high risk of infection with the related pathogen, M.
tuberculosis do not become infected, and a specific re-
gion of the human genome has been associated with
both SICCT test negativity and a major innate immune
pathway associated with infection and progression of
human TB [31]. Potentially, the control resistant cattle
employ similar innate immune defence mechanisms and
further research in this area would be warranted.
The second and third group of susceptible animals are
unable to prevent establishment of infection, as evi-
denced by their positive reaction to the SICCT. How-
ever, the outcome following infection is variable in cattle
[17, 32] and the evidence presented in this paper would
suggest that there are at least two outcomes to M. bovis
infection: detectable disease (VLs) versus no detectable
visible lesions (NVLs), which are under some distinct
genetic control. One hypothesis considered is that the
NVLs were simply animals tested at early stages of infec-
tion with lesions too small to detect under the naked
eye. If so, it was anticipated that the underlying genetics
of susceptibility would be indistinguishable for the two M.
bovis infection phenotypes. Instead, different loci were as-
sociated with VLs (versus controls) compared to NVLs,
and there was additional variance explained by chromo-
somes for the NVLs not found for the VLs. Second, gen-
etic differences were also detected when the VLs were
contrasted with the NVLs. There was moderate genome-
wide SNP heritability detected between the VLs vs NVLs
(h2= 0.29 (± 0.06)) and chromosomes were found to
harbour variants that distinguished the two case pheno-
types. However, a degree of genetic control underlying
bTB resistance appears to be shared between the two M.
bovis infection outcomes. When grouped together (and
contrasted against the controls) variance was attributed to
several chromosomes and the genome-wide SNP herit-
ability was moderate (h2= 0.22 (± 0.04)).
Since the traits defined in this study are dependent on
statutory screening tests performed on the national herd,
their properties could affect the categorisation of ani-
mals into the three phenotypes considered here. The
SICCT test was used to first classify dairy cows as cases
(VLs and NVLs) and controls. The test has a high speci-
ficity for both the standard and severe interpretations
[33, 34], which is sufficiently high to result in a high
positive predictive value (PPV). In addition, even with
this small subset of false positives for the SICCT test,
there is only very small heritability in the liability to test
positive when healthy [35]. Therefore, it is highly likely
that with a positive reaction to the SICCT test, all of the
cases, which constitute both the VL and NVL pheno-
types, are likely infected with M. bovis and the genetic
variation associated with bTB arises from infection. In
contrast to specificity, the sensitivity of the SICCT test is
moderate with a range of 50–80% for a single test [33,
36–38], suggesting a small proportion of the controls
may be false negatives. The design of the current study
had strict criteria for selecting controls maximising that
they were healthy exposed animals: identified animals
were negative on multiple occasions for the SICCT test
herd breakdown and were also subjected to retrospective
checks to ensure their continuing healthy status. Fur-
thermore, herds undergoing breakdowns are subject to
repeated short-interval testing and remain closed until
the whole herd is SICCT negative, thus the breakdown
process has a high sensitivity, removing infected animals
and leaving the uninfected ones in the herd. Despite the
imperfect SICCT test properties, genetic variants associ-
ated with M. bovis susceptibility were detected for the
case phenotypes (when contrasted against controls),
which supports the criteria used to diagnose the cases
and controls in this study.
The second diagnostic test used in this study was car-
case abattoir examination for signs of pathology to clas-
sify cases (SICCT-positives) as VLs or NVLs. This test
has a high specificity because the majority (95–100%) of
visibly lesioned SICCT test reactors are also culture
positive for M. bovis [39], supporting the VL infection
status. However, the sensitivity of carcase abattoir exam-
ination is moderate at best, at around ~45% [40]. This
implies that a proportion of SICCT-positives with lesions
may not be confirmed as VLs under examination, but
instead are misclassified as NVLs. It is argued that the
sensitivity of lesion detection is compromised by prevail-
ing abattoir conditions, such as limited time and visual
rather than microscopic inspections [40, 41]. If so, an
NVL diagnosis would represent an early stage of in-
fection not yet progressed to the disease presentation
observed in the VL phenotype. With the hypothesis that
sensitivity of carcase examination is influenced to a large
degree by abattoir conditions, little genetic differences
would be expected between the NVL and VL phenotype.
However, variants unique to each case phenotype and
chromosomal variation distinguishing the NVLs and
VLs were observed, suggesting there may be at least two
host phenotype responses to M. bovis infection in dairy
cattle. Variation in pathology of SICCT-positives may
also be partly genetically determined and indicative of
different host responses or pathogen handling. Thus, a
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proportion of animals with the NVL phenotype may be
able to control and contain M. bovis, an outcome which
may lead to latent infection [32].
Distinct genetic loci may also play a role in the ob-
served spectrum of M. tuberculosis infection phenotypes
in humans with recent candidate gene case–control
studies identifying polymorphisms in IL10 [42] and
TLR9 [43] associated with latent TB but not active TB.
In addition, a human TB GWAS, incorporating a num-
ber of infection outcomes, identified SNPs in the HLA
class II region significantly associated with pulmonary
TB and M. tuberculosis infection whilst no variants were
significantly associated with all confirmed TB cases [14].
Breeding for bTB resistance in cattle
The existence of a host genetic component to bTB
resistance in dairy cattle is well established. Thus, a gen-
etic strategy to reduce bTB prevalence is a credible
option, using pedigree-based EBVs and/or a whole gen-
ome selection approach (gEBVs). Although the genetic
results in the present study suggest the host genetics
underlying the two M. bovis infection outcomes are
governed, in part, by distinct genetic variants, variance
was attributed to many chromosomes for all cases (VLs
and NVLs), altogether capturing 24% of the phenotypic
variation. Thus, when using the SICCT test to diagnose
infection, genetic variation for susceptibility to M. bovis
infection exists among dairy cows. Given the high PPV
of the SICCT test, it is reasonable to conclude that both
NVLs and VLs are infected with M. bovis, and therefore
using SICCT test data to produce EBVs or gEBVs would
ensure breeding for reduced susceptibility to M. bovis
infection in cattle.
Conclusions
This study identified genomic regions and chromosomes
significantly associated with bTB resistance to infection
in sampled Northern Ireland dairy cattle. RH mapping
identified three loci distinct for the NVL phenotype on
BTA17, BTA22 and BTA23, whilst a region on BTA13 was
associated with the VL phenotype. The region with the
strongest evidence of association on BTA23 contained
immune-related genes, including GCLC and members of
the BoLA class IIb region. Furthermore, the two QTLs on
BTA22 and BTA23 were nearby bTB resistance QTLs
identified in two other bTB GWAS studies. Chromosome
heritability analysis attributed variance to six and thirteen
chromosomes for the VL and NVL phenotypes, respect-
ively and grouping the M. bovis outcomes (controls vs all
cases) resulted in variance attributed to nine chromo-
somes. Furthermore, nine chromosomes were found to
harbour variants that distinguished the NVLs and VLs.
These findings suggest the host genetics of M. bovis infec-
tion outcomes is governed by distinctive genetic variation,
along with shared genetic variants. It follows that
there are at least two distinct outcomes to diagnosed
M. bovis infection in dairy cattle, which may be indi-
cative of different host responses or pathogen
handling.
Material and methods
Sample collection
As described in Bermingham et al. [6], samples were
taken from cattle at slaughter that tested positive under
either the standard or severe interpretation of the
SICCT test between August 2008 and June 2009 along-
side Northern Ireland’s routine screening of herds. De-
scriptions of the SICCT test interpretations can be
found in Lesslie and Herbert [44] and Morrison et al.
[45], but to note the severe interpretation is adopted
under certain conditions whereby the cut-off point is
lowered to enhance the sensitivity of the test. As per
routine bTB surveillance, SICCT-positive carcases were
examined in the abattoir for signs of pathology and upon
detection tissue was sampled for bacterial culturing and
molecular typing of M. bovis. High-prevalence herds
with sampled SICCT-positive cows were also sourced
for SICCT-negative animals.
Phenotype definition
Three phenotypes were defined based on the outcomes
of the diagnostic tests SICCT and carcase abattoir exam-
ination. First, SICCT-positives, under either the standard
or severe interpretation, were defined as cases. Next,
cases were sub-categorised into (i) animals confirmed
for M. bovis infection with evidence of pathology in the
form of detectable lesions from carcase abattoir examin-
ation, positive culture and molecular confirmation of M.
bovis (VLs) and (ii) animals unconfirmed for M. bovis
infection as no lesions were detected from carcase
abattoir examination (NVLs). Controls were SICCT-
negatives on multiple occasions before, during and after
a herd breakdown, and were sourced from high bTB
prevalence herds (defined as herds that had a minimum
of 2 VLs). In addition, longitudinal data were available
and examined to ensure the healthy status of the
controls over time [6].
Selecting phenotype samples
VLs and controls samples were selected in a previous
case–control study (see [6]). Since VLs comprised of
both standard and severe reactors, NVLs were selected
under both interpretations of the SICCT test. To have a
set of epidemiologically comparable animals for the 2
case phenotypes, female NVLs were selected from herds
already sampled for VLs [6]. A total of 873 NVLs met
the above criteria, of which 625 and 248 were positive
under the standard and severe interpretation of the
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SICCT test, respectively. Due to the lower cut-off
threshold applied under the severe interpretation, the
probability that a cow was truly infected when it tested
positive under the severe interpretation was estimated as
the PPV [46] for each herd: PPV ¼ Se:pSe:pð Þþ 1−Spð Þ 1−pð Þ ;
where Se was the sensitivity, Sp was the specificity and p
was the true prevalence: p ¼ p′þSp−1SeþSp−1 , where p’ was the
proportion of SICCT-positive animals of the total herd.
Since some herds had SICCT test positive animals from
more than test time-point between August 2008 and June
2009 the highest calculated herd prevalence from that
timeframe was used. Values of 0.659 and 0.998 for the Se
and Sp for the severe interpretation of the SICCT test
were used, respectively, and fall within the range of esti-
mates found in the literature [33]. A total of 223 severe re-
actors had a PPV ≥ 0.90 and were shortlisted for
genotyping along with the 625 standard reactors.
SNP chip genotyping and quality control
DNA from blood samples had been previously extracted
(see [6]). After taking into account low DNA concentra-
tions, 837 NVLs, comprising 616 standard and 221
severe reactors remained. From the previous bTB case–
control study a total of 27 VLs that failed quality control
due to a low call rate (<90%) were also re-genotyped [6].
In total, 864 samples were genotyped with the BovineHD
Genotyping BeadChip (Illumina Inc., San Diego, CA,
USA) by Edinburgh Genomics. A high-density SNP
dataset was available (592 VLs and 559 controls [6]) and
combined the two genotype datasets together comprised
of 2015 animals genotyped at 777,962 SNP markers,
categorised into 619 VLs, 837 NVLs and 559 controls.
Quality control of the data was implemented prior to
analysis. Samples with greater than 10% missing geno-
types and were removed. Pairs of animals with an aver-
age identity by state ≥0.90 were removed, carried out in
GenABEL [47]. Marker reproducibility was assessed [48]
by comparing the VLs re-genotyped in this study to their
genotypes from the previous study [6]. Twenty re-
genotyped VLs were used to contrast the SNP calls
between the two genotype datasets. In total, 19,808 SNPs
did not match between both the genotype datasets in
one or more animal and these SNPs were removed (2.5%
of SNPs). Next, the two genotype datasets were cleaned
separately prior to merging [49]. SNPs were discarded if
they were monomorphic (MAF < 0.05), had greater than
10% missing genotypes, deviated from Hardy-Weinberg
Equilibrium at a critical rejection region of 8.1 × 10−6
and were on sex chromosomes. Following quality con-
trol the two genotype datasets were merged based on
common SNPs. The final dataset comprised 1966 ani-
mals genotyped at 538,231 autosomal SNP markers,
categorised into 607 VLs, 800 NVLs and 559 controls.
Analysis
Genetic analyses were carried out where the bTB status
(phenotypes) was coded as a binary trait (0, 1) for VLs
(controls vs VLs), NVLs (controls vs NVLs), all cases
(controls vs SICCT positives) and NVLs vs VLs.
Multi-dimensional scaling (MDS) was performed for
each binary trait using the genomic relationship matrix
(GRM) to assess population structure amongst animals
using GenABEL [47]. No genetic structuring was ob-
served amongst the animals or clustering of distinctive
of the VLs, NVLs, standard SICCT reactors, severe
SICCT reactors and controls (Additional file 6). There-
fore, population stratification was not considered, other
than to account for relatedness using the GRM.
Regional heritability (RH) mapping was conducted
[20] to identify regions of genetic variance associated
with M. bovis infection outcomes, carried out using
DISSECT [50]. RH mapping of the whole genome
was conducted using 100-SNP window sizes shifted
every 50 SNPs and 50-SNP window sizes shifted every
25 SNPs. Fine RH mapping of chromosomes with
QTLs detected above and just below significance
levels was conducted using 30-SNP window sizes
shifted every 15 SNPs. The GRM for each region was
fitted separately as a random effect in a linear mixed
model along with the whole-genome GRM:
y¼Wαþuþgrþe
where y is a vector of phenotypes, α is a vector of fixed
effects with its incidence matrix W, u is a vector of ran-
dom additive genetic effects (the polygenic effect), g is a
vector of the random regional additive genetic effects of
SNPs in a pre-defined window and e is a vector of the
random residual effects. Fixed effects included were
breed (Holstein vs Friesian), age at the start of the herd
breakdown-initiating SICCT test, year, season and test
reason for the herd breakdown-initiating SICCT test and
highest estimated herd bTB prevalence during the break-
down. Random effects were distributed as u ~ N(0,
Gσ2a), gr ~ N(0, Qσ
2
r) and e ~ N(0, Iσ
2
e) where matrices
G, Q and I were the whole-genome GRM, a regional
GRM using SNPs within a window and an identity
matrix, respectively. Phenotypic variance was calculated
as σ2p = σ
2
a + σ
2
r + σ
2
e, where σ
2
a, σ
2
e and σ
2
r are the additive
genetic, residual and regional additive genetic variance,
respectively, and heritability for each region was esti-
mated as h2r = σ
2
r/σ
2
p. The null hypothesis was a linear
mixed model without the regional additive genetic effect
(i.e. only the polygenic effect was fitted):
y¼Wαþuþe
Significance at each window was assessed using the
likelihood ratio test (LRT) calculated for the model
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fitting regional variance (fitting both whole-genome and
regional GRM) against the null hypothesis of no regional
variance (fitting only the whole-genome GRM). The test
statistic was assumed to follow a chi-square distribution.
Windows at the ends of chromosomes that did not meet
the pre-defined window size were discarded. Bonferroni
correction was implemented to account for multiple
testing with half the number of windows used due to
overlapping windows. After Bonferroni correction, LRT
thresholds were 18.32 and 13.95 for the 100-SNP win-
dow scan, 19.51 and 15.26 for the 50-SNP window scan
and 20.62 and 16.23 for the 30-SNP window scan, for
genome-wide (P < 0.05) and suggestive significance (one
false positive per genome scan), respectively.
To determine how genetic variation associated with M.
bovis infection outcomes was apportioned across the
bovine genome the variance attributable to each chromo-
some was estimated [51], implemented in GCTA [52]. A
GRM for each chromosome was produced using its re-
spective SNPs and chromosome heritability was calculated
using a single chromosome decomposition approach. The
GRM for each chromosome was fitted separately, along
with the GRM for the whole genome excluding the target
chromosome:
y¼Wαþu−cþgcþe
where gc is a vector of random genetic effects for chromo-
some c, with gc ~ N(0, Gcσ
2
c) where Gc is the GRM for
chromosome c and u-c is the whole-genome polygenic ef-
fect for the remaining SNPs distributed as N(0, G-cσ
2
a(−c))
where G-c is the GRM for all SNPs excluding those on
chromosome c. For chromosome c the phenotypic vari-
ance was calculated as σ2p = σ
2
a(−c) + σ
2
c + σ
2
e and heritability
was estimated as h2c = σ
2
c/σ
2
p.
If a trait is of a highly polygenic nature a strong
linear relationship between chromosome length and
the proportion of variance explained the chromosome,
such as height, is expected [51]. A linear regression
between the proportion of variance explained by each
chromosome and chromosome length was carried out.
Chromosome length in base pairs was taken from http://
www.ncbi.nlm.nih.gov/genome?term=bos%20taurus, which
used the UMD3.1.1 genome assembly.
A genome-wide association analysis was also carried
and details of the methods employed is provided in the
supplementary material (Additional file 1).
Additional files
Additional file 1: Description of methods and results obtained from a
genome-wide association study. (DOCX 16 kb)
Additional file 2: Significant SNPs using a linear mixed model for each
case–control classifications for M. bovis infection. For each trait, the table
shows chromosome, significant SNPs, reference SNP id number (rs id),
position (in base pairs), the minor allele, minor allele frequency beta
coefficient (substitution effect of the minor allele) and P-value of the
GWAS analysis (DOCX 15 kb).
Additional file 3: Genome-wide association analysis for controls vs NVLs
a Manhattan plot displaying the –log10(P- value) of association of each
SNP with the phenotype with respect to genomic position and b Q-Q
plot of observed P-values against the expected P-values with a genomic
inflation factor of λ = 1.004. Genome-wide (P < 0.05) and suggestive
significance (one false positive per genome scan) P-value thresholds are
shown as a dashed and dotted line, respectively (PDF 2422 kb).
Additional file 4: Genome-wide association analysis for controls vs
cases a Manhattan plot displaying the –log10(P- value) of association of
each SNP with the phenotype with respect to genomic position and b
Q-Q plot of observed P-values against the expected P-values with a gen-
omic inflation factor of λ = 1.01. Genome-wide (P < 0.05) and suggestive
significance (one false positive per genome scan) P-value thresholds are
shown as a dashed and dotted line, respectively (PDF 2501 kb).
Additional file 5: Genome-wide association analysis for NVLs vs VLs a
Manhattan plot displaying the –log10(P- value) of association of each SNP
with the phenotype with respect to genomic position and b Q-Q plot of
observed P-values against the expected P-values with a genomic inflation
factor of λ = 1.005. Genome-wide (P < 0.05) and suggestive significance
(one false positive per genome scan) P-value thresholds are shown as a
dashed and dotted line, respectively (PDF 2438 kb).
Additional file 6: Multi-dimensional scaling (MDS) analysis using a
similarity distance matrix calculated from the identity-by-descent
genomic kinship matrix. Analysis was done for the each case/control
classification with colours reflecting the different phenotypes and are
plotted as a controls vs VLs, b controls vs NVLs, c controls vs cases
and d NVLs vs VLs (PDF 43 kb).
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